Aberrant expression of transmembrane mucins promotes tumor progression and interferes with immunological and medicinal elimination of cancer cells. In a recent article, Pedram et al. directed an attenuated bacterial mucin-specific protease to HER2-positive tumor cells and observed decreased tumor growth rates and extended survival of mice bearing HER2-positive tumors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tips.2023.08.011 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!